此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation Of The Effect Of Low-Level Laser Therapy On Masseter Muscle Versus Therapeutic Ultrasound On Patients With Myofascial Pain Disorder : A Randomized Clinical Trial

2026年8月28日 更新者:mohamed mostafa、Cairo University

Myofascial pain dysfunction (MPD) is one of the most common causes of chronic orofacial pain, primarily affecting the masticatory muscles such as the masseter and temporalis. It leads to facial pain, muscle tenderness, and restricted mouth opening, significantly impacting patients' quality of life and daily function.

Despite the wide range of conservative treatment modalities-such as medications, splint therapy, and physiotherapy-there is still no universally accepted approach that provides consistent and long-lasting relief.

Low-level laser therapy (LLLT) and therapeutic ultrasound (US) are two non-invasive physical modalities frequently used in dentistry for pain control and tissue healing. Each has shown promising outcomes individually.

Azizi et al. (2007) demonstrated that LLLT at 780 nm can significantly reduce pain and tenderness for up to three months, while Khairy (2018) reported notable pain relief and improved jaw function using pulsed ultrasound at 1.5 W/cm² for 5 minutes over 10 sessions.

However, direct comparative evidence between LLLT and therapeutic ultrasound in patients with myofascial pain dysfunction is still lacking.

This knowledge gap prevents clinicians from identifying which modality offers superior short- and long-term outcomes in terms of pain reduction, muscle function improvement, and patient satisfaction.

Therefore, this study aims to compare the efficacy of low-level laser therapy versus therapeutic ultrasound in the management of myofascial pain dysfunction, using standardized treatment parameters from the most evidence-based protocols in the literature.

研究概览

详细说明

Myofascial pain dysfunction (MPD) is one of the most common causes of chronic orofacial pain, typically involving the masticatory muscles such as the masseter and temporalis. It is characterized by localized muscle tenderness, trigger points, and functional limitation of jaw movements. The condition affects a significant percentage of adults and can lead to persistent discomfort and impaired quality of life.

The etiology of MPD is multifactorial, including parafunctional habits such as bruxism, psychological stress, trauma, malocclusion, and muscle overuse. Because of this complex etiology, management often requires a multimodal approach combining behavioral, pharmacological, and physical therapies.

2. Myofascial Pain and Physical Modalities

Conservative physical modalities are widely used as first-line treatments for MPD because they are non-invasive, safe, and easily applicable. These modalities include ultrasound therapy, low-level laser therapy, transcutaneous electrical nerve stimulation (TENS), and thermotherapy. Among these, therapeutic ultrasound (US) and low-level laser therapy (LLLT) have gained increasing attention for their effectiveness in pain reduction and tissue healing without pharmacological side effects.

3. Low-Level Laser Therapy (LLLT)

Low-level laser therapy, also referred to as photobiomodulation therapy, uses light energy at specific wavelengths to produce photochemical and photothermal effects in tissues. These effects lead to enhanced cellular metabolism, increased microcirculation, improved oxygen supply, and stimulation of ATP production, which collectively accelerate healing and reduce inflammation.

Several studies have explored the role of LLLT in treating myofascial pain dysfunction.

Azizi et al. (2007) evaluated the effect of LLLT (780 nm, 10 mW) applied to the masseter, temporalis, medial, and lateral pterygoid muscles. Each region received 1200 mJ of energy per session, with twelve sessions performed over four weeks. The study demonstrated a significant reduction in pain and muscle tenderness and an improvement in mandibular function. Importantly, these therapeutic effects persisted up to three months after the completion of treatment, indicating both short-term and long-term efficacy.

Other research supports these findings, confirming that LLLT promotes analgesia by modulating nerve conduction velocity, reducing bradykinin and histamine release, and stimulating mitochondrial cytochrome oxidase activity. The cumulative evidence suggests that LLLT provides a safe, effective, and sustainable method for managing myofascial pain.

4. Therapeutic Ultrasound (US)

Therapeutic ultrasound is a commonly used modality in physiotherapy and dentistry. It transmits acoustic energy through tissues, producing both thermal and mechanical effects. These effects enhance blood flow, increase cell membrane permeability, and promote tissue repair while reducing muscle spasm and pain.

Khairy (2018) conducted a randomized clinical study comparing phonophoresis and ultrasound therapy in myofascial pain dysfunction syndrome. The study applied pulsed ultrasound at 1.5 W/cm² for 5 minutes per session, over ten sessions spanning three weeks. The ultrasound head was moved in circular motions across the affected masseter muscle using coupling gel.

Results showed significant improvements in pain intensity (VAS), maximum mouth opening (MMO), and muscle tenderness compared with baseline values. This confirms the beneficial role of pulsed ultrasound in decreasing pain and improving masticatory muscle function.

The therapeutic benefits of ultrasound are attributed to its mechanical micro-massage effect, which enhances cellular exchange, reduces edema, and improves local metabolism. The pulsed mode, in particular, minimizes thermal buildup and focuses on non-thermal biostimulation, making it suitable for inflamed or tender tissues such as the masseter.

5. Comparison between LLLT and Ultrasound Therapy

Both LLLT and ultrasound therapy share common goals-reducing pain, decreasing muscle stiffness, and improving jaw function-but act through different biophysical mechanisms. LLLT works primarily through photochemical cellular activation, while ultrasound acts via mechanical micro-vibration and mild thermal stimulation.

Although both modalities have been proven individually effective, few studies have directly compared their outcomes in myofascial pain dysfunction.

Combining evidence from Azizi (2007) and Khairy (2018) indicates that both approaches are effective within short treatment durations (3-4 weeks) and produce measurable improvements in pain and muscle performance. However, the relative superiority of one modality over the other remains undetermined, justifying the need for a direct head-to-head comparison using standardized settings.

研究类型

介入性

注册 (估计的)

36

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion criteria:

Patients should have one or more signs and symptoms of these

  • Symptoms: Patients who report typical symptoms of myofascial pain , such as pain, discomfort, especially when opening or closing the mouth.
  • Mouth Opening: Limited range of motion or difficulty with full mouth opening.
  • Pain: Pain or tenderness around the TMJ, often radiating to the ear, temple, or neck.
  • Patients who will be free from any systemic diseases that affect temporomandibular joint.
  • Patients who will be ready to give informed consent.

Exclusion criteria:

  • Blood dyscrasias and systemtic diseases.
  • Previous surgery of the affected joint.
  • Infection
  • Patients with previous facial fracture.
  • Patients who will be under another type of treatment for TMD (e.g., occlusal splints, pharmacological drugs, or head and neck surgery).
  • Patients who will not attend the proposed treatment sessions or follow-up visits.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:Evaluation The Effect Of Low-Level Laser Therapy On Masseter Muscle On Patients With Myofascial Pain

Low-Level Laser Therapy (LLLT) utilizes light energy, typically in the red or near-infrared spectrum (630-830 nm), to stimulate photochemical reactions in the target tissues. The absorbed photons enhance mitochondrial activity, increase ATP production, improve local blood circulation, and reduce inflammatory mediators such as prostaglandins and bradykinin. These actions contribute to analgesia, relaxation of muscle fibers, and acceleration of tissue repair.

In the study by Azizi et al. (2007), LLLT at 780 nm with a total energy of 1200 mJ per treated region significantly reduced pain and muscle tenderness, and these imp

Given that both modalities promote pain relief and muscle recovery through distinct biological pathways-LLLT via photobiomodulation and US via mechanical and thermal stimulation-a direct comparison between them can determine which produces superior clinical outcomes in terms of pain reduction, functional improvement, and duration of therapeutic effect.
实验性的:Evaluation Of The Effect Of therapeutic Ultrasound On Patients With Myofascial Pain Disorder

Therapeutic Ultrasound (US), on the other hand, transmits mechanical acoustic energy through soft tissues, producing micro-vibration and mild thermal effects. These effects increase cellular permeability, stimulate fibroblast activity, enhance microcirculation, and facilitate the resorption of inflammatory exudates. The pulsed mode specifically provides a non-thermal biostimulatory effect, making it suitable for acute or painful conditions.

Khairy (2018) reported that pulsed ultrasound at 1.5 W/cm² for 5 minutes per session over ten sessions produced significant reductions in pain intensity and improvement in mouth opening in patients with myofascial pain dysfunction.

Given that both modalities promote pain relief and muscle recovery through distinct biological pathways-LLLT via photobiomodulation and US via mechanical and thermal stimulation-a direct comparison between them can determine which produces superior clinical outcomes in terms of pain reduction, functional improvement, and duration of therapeutic effect.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
pain
大体时间:measured at baseline ,1week, 2weeks, 3weeks, 4weeks, 1months,3months, 6months
pain severity will be assessed using Visual analogue scale 0-10
measured at baseline ,1week, 2weeks, 3weeks, 4weeks, 1months,3months, 6months

次要结果测量

结果测量
措施说明
大体时间
Maximum interincisal opening
大体时间:baseline , 1week, 2weeks,3weeks, 4weeks, 1month,3months, 6months
Maximum interincisal opening will be measeured in millimeters using digital caliper
baseline , 1week, 2weeks,3weeks, 4weeks, 1month,3months, 6months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年9月1日

初级完成 (估计的)

2027年1月1日

研究完成 (估计的)

2027年2月1日

研究注册日期

首次提交

2026年8月28日

首先提交符合 QC 标准的

2026年8月28日

首次发布 (实际的)

2026年9月2日

研究记录更新

最后更新发布 (实际的)

2026年9月2日

上次提交的符合 QC 标准的更新

2026年8月28日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • tmj Myofascial Pain Disorder

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅